UiPath (NYSE:PATH) Given New $25.00 Price Target at Needham & Company LLC
UiPath (NYSE:PATH – Free Report) had its price target boosted by Needham & Company LLC from $20.00 to $25.00 in a report released on Friday morning, Benzinga reports. The brokerage currently has a buy rating on the healthcare company’s stock. Several other equities analysts have also recently weighed in on PATH. Mizuho raised their price […]
More Stories
NVIDIA (NASDAQ:NVDA) Shares Down 1.3% – What’s Next?
NVIDIA Co. (NASDAQ:NVDA – Get Free Report)’s share price fell 1.3% on Monday . The company traded as low as...
Pharming Group (NASDAQ:PHAR) Stock Price Down 6.4% – What’s Next?
Pharming Group (NASDAQ:PHAR – Get Free Report)’s stock price traded down 6.4% during mid-day trading on Monday . The company...
Coeur Mining (NYSE:CDE) Trading 5.2% Higher – What’s Next?
Coeur Mining, Inc. (NYSE:CDE – Get Free Report) shares rose 5.2% during trading on Monday . The company traded as...
IonQ (NYSE:IONQ) Trading Down 18.6% – Here’s What Happened
IonQ, Inc. (NYSE:IONQ – Get Free Report)’s stock price was down 18.6% on Monday . The stock traded as low...
Energy Transfer (NYSE:ET) Trading 1% Higher – What’s Next?
Energy Transfer LP (NYSE:ET – Get Free Report)’s share price shot up 1% on Monday . The company traded as...
BrainChip Holdings Ltd (OTCMKTS:BRCHF) Short Interest Up 11.1% in October
BrainChip Holdings Ltd (OTCMKTS:BRCHF – Get Free Report) was the target of a significant growth in short interest in October....